Latest Articles about HNT

Molina Hits a New 52-Week High - Analyst Blog

Zacks Equity Research — Fri, 10 May 2013 19:24:34 Z

On May 9, 2013, shares of Molina Healthcare Inc. ( MOH ) reached a 52-week high of $35.98. The momentum was driven by the company's strong earnings in the first quarter of 2013, which

UnitedHealth Stays at Neutral - Analyst Blog

Zacks Equity Research — Fri, 10 May 2013 01:24:51 Z

We are reiterating out Neutral recommendation on UnitedHealth Group Inc . ( UNH ). Though bottom line fell short of the year-ago earnings, it was in line with the Zacks Consensus Estimate.

Aetna Closes Coventry Takeover - Analyst Blog

Zacks Equity Research — Thu, 09 May 2013 22:24:56 Z

Recently, Aetna Inc. ( AET ) completed the acquisition of Coventry Health Care Inc., which was announced in August last year. As a result, Aetna raised its operating earnings guidance for

Coventry Beats Earnings Estimate - Analyst Blog

Zacks Equity Research — Wed, 01 May 2013 23:43:01 Z

Coventry Health Care Inc. ( CVH ) reported first-quarter 2013 operating earnings per share of $1.00, which surpassed the Zacks Consensus Estimate of 79 cents as well as the prior-year

Humana Reports Strong 1Q Earnings - Analyst Blog

Mark Vickery — Wed, 01 May 2013 20:33:01 Z

Humana Inc. 's ( HUM ) first-quarter 2013 operating earnings came in at $407 million or $2.69 per share. The results substantially surpassed the Zacks Consensus Estimate of $1.78 as well as

Health Net's Earnings Misses Est - Analyst Blog

Zacks Equity Research — Tue, 30 Apr 2013 21:31:01 Z

Health Net Inc. 's ( HNT ) first-quarter 2013 operating income, which comprises combined net earnings from the Western Region Operations and Government Contracts segments, came in at $8.2

Earnings Beat for ABAX, Sluggish Overall - Analyst Blog

Zacks Equity Research — Sat, 27 Apr 2013 00:00:01 Z

Provider of portable blood analysis systems for human and veterinary patient-care, Abaxis Inc. ( ABAX ) reported fourth-quarter fiscal 2013 earnings per share ("EPS") of 30 cents,

Will Health Net jump with earnings?

David Russell — Fri, 26 Apr 2013 21:15:03 Z

The bulls want to start next week with a bang as Health Net reports earnings. optionMONSTER's Heat Seeker monitoring system detected the purchase of some 2,000 June 32.50 calls for $0.54 and

BSX Beats Y/Y Earnings, Guides Low - Analyst Blog

Zacks Equity Research — Fri, 26 Apr 2013 00:12:11 Z

Boston Scientific ( BSX ) reported adjusted earnings per share (after considering certain adjustments other than amortization expense) ("EPS") of 10 cents in the first quarter of

Coventry Raised to Outperform - Analyst Blog

Zacks Equity Research — Wed, 24 Apr 2013 22:11:36 Z

On Apr 23, 2013, we upgraded Coventry Health Care Inc. ( CVH ) to Outperform based on strong fundamentals, reflected by higher revenues, strong balance sheet, efficient capital deployment

TMO's Earnings Beat, LIFE Buyout on Track - Analyst Blog

Zacks Equity Research — Wed, 24 Apr 2013 20:15:03 Z

Thermo Fisher Scientific ( TMO ) reported adjusted earnings per share ("EPS") of $1.37 in the first quarter of fiscal 2013. This was 6.2% ahead of the Zacks Consensus Estimate of

AmSurg's Rev and Earnings In Line - Analyst Blog

Zacks Equity Research — Wed, 24 Apr 2013 17:30:01 Z

AmSurg Corp. 's ( AMSG ) first-quarter 2013 adjusted earnings per share ("EPS") of 52 cents were 2 cents ahead of the year-ago quarter EPS and in line with the Zacks Consensus

Health Net, Inc. Enters Oversold Territory - Tale of the Tape

Zacks Equity Research — Tue, 23 Apr 2013 20:14:42 Z

Health Net, Inc. 's ( HNT ) share price has entered into oversold territory with a stochastic value of 18.534. The Zacks Consensus Estimate on the company's earnings for year ending

UnitedHealth Reports In-Line Earnings - Analyst Blog

Zacks Equity Research — Thu, 18 Apr 2013 20:10:29 Z

UnitedHealth Group Inc . ( UNH ) reported its first-quarter 2013 earnings of $1.16 per share, in line with the Zacks Consensus Estimate. Earnings, however, declined 11.4% on a

Coventry Upgraded to Strong Buy - Analyst Blog

Zacks Equity Research — Thu, 11 Apr 2013 21:08:41 Z

On Apr 10, 2013, Zacks Investment Research upgraded Coventry Health Care Inc. ( CVH ) to a Zacks Rank #1 (Strong Buy). Why the Upgrade? Coventry has strong fundamentals, including